Bumrungrad Hospital PCL BUHPF
Morningstar’s Analysis
1-Star Price
PREMIUM
5-Star Price
PREMIUM
Economic Moat
PREMIUM
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible for overseeing the methodology that supports the quantitative fair value. As an employee of Morningstar, Inc., Mr. Davidson is guided by Morningstar, Inc.'s Code of Ethics and Personal Securities Trading Policy in carrying out his responsibilities. For information regarding Conflicts of Interests, click here .
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile
Bumrungrad Hospital PCL is a multispecialty hospital in Thailand, with diagnostic, therapeutic, and intensive care facilities. The firm receives virtually all of its revenue from its hospital operations at the Bumrungrad International Hospital in Bangkok. Inpatient and outpatient services each contribute roughly half of the hospital's revenue. The remainder of the firm's operations are based in Mongolia, at the Ulaanbaatar Songdo Hospital. Its outpatient services include centers for diabetes, orthopedics, physical therapy, pediatrics, neurology, pulmonology, urology, and cardiology. Non-Thai patients contribute the largest proportion of patient revenue.
Bangkok, 10110, Thailand